1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. INNOVA CAPTAB LTD.
Innova Captab Ltd.
NSE: INNOVACAP | BSE: 544067

Innova Captab Live Share Price Today, Share Analysis and Chart

aboutInnova Captab Ltd. is a vertically integrated pharmaceutical company with a presence across the entire value chain, including research and development (R&D), manufacturing, and marketing. The company operates in three primary business segments: Contr... Read More
ANDA Approvals
Ask AI about Innova Captab
1013.00-12.30(-1.20%)
6,907
NSE+BSE Volume

NSE 02 Nov, 2026 10:14 AM (IST)

Portfolio

Alert

My Notes

Turnaround PotentialThese stocks have average financials and valuation, but strong momentum indicating buying interestView SimilarEmbed DVM

Innova Captab Stock Price Analysis

Day Price Range

-1.2% 1 Day return
1013 (LTP)
994.61,024
LowHigh

Week Price Range

2.6% 1 Week return
1013 (LTP)
969.71,093.9
LowHigh

Month Price Range

-13.3% 1 Month return
1013 (LTP)
9521,193
LowHigh

52 Week Price Range

21.9% 1 Year return
1013 (LTP)
6221,353.5
LowHigh

Innova Captab Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

EPS forecast

CURRENT EPS
24.6
AVG. ESTIMATE
33.6
LOW ESTIMATE
33.6
HIGH ESTIMATE
33.6
CURRENT EPS
AVG. ESTIMATE

Consensus Recommendation

2 ANALYST Recommendations
BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Innova Captab Technical Analysis

Innova Captab EMA & SMA

Bearish-6
1 bullish, 7 bearish
Bullish1
Bearish7
5 Day1033.5
10 Day1036.8
12 Day1041.5
20 Day1061.9
26 Day1072.3
50 Day1077.2
100 Day1031.2
200 Day954.1

Innova Captab Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202637.5%
Week43.4%
Month45.2%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Innova Captab Resistance and Support

1034.23
Pivot
First Resistance1058.8
Second Resistance1092.2
Third Resistance1116.8
First Support1000.8
Second Support976.2
Third Support942.8
Day RSI41.1
Day MACD-30.8
Day MFI23.1
Day MACD Signal Line-30.9

Innova Captab Beta

1 Month0.1
1 Year0.4
3 Month0.1
3 Year-

Innova Captab Price Change Analysis

↓-13.3%
Over 1 Month
LowHigh
9521193
↑4.0%
Over 3 Months
LowHigh
925.21353.5
↑34.7%
Over 6 Months
LowHigh
7901353.5
↑21.9%
Over 1 Year
LowHigh
6221353.5

Innova Captab Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Manoj LohariwalaPromoter16,636,44629.1 %
Gian Parkash AggarwalPublic5,832,46410.2 %
Clarus Capital IDii2,045,9353.6 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Innova Captab Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SBI MUTUAL FUNDBulkPurchase30 Sep 20261080833,250BSE
GIAN PARKASH AGGARWALBulkSell30 Sep 20261080.041,550,000BSE
GRAVITON RESEARCH CAPITAL LLPBulkSell02 Jan 2024565.55345,941NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase02 Jan 2024566345,941NSE
GRAVITON RESEARCH CAPITAL LLPBulkSell01 Jan 2024525.70477,528NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase01 Jan 2024525.68477,528NSE
MANSI SHARE AND STOCK ADVISORS PVT LTDBulkSell29 Dec 2023535.24765,523NSE
MUSIGMA SECURITIESBulkSell29 Dec 2023508.32461,621NSE
ELIXIR WEALTH MANAGEMENT PRIVATE LIMITEDBulkSell29 Dec 2023512.06283,277NSE
GOLDMINE STOCKS PRIVATE LIMITEDBulkSell29 Dec 2023502.89359,567NSE

Innova Captab Corporate Actions

Innova Captab Dividend history and yield

Innova Captab dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Innova Captab dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
130 Jan 2026
2INTERIM30 Jan 2026Equity Share

Innova Captab Board Meetings

Innova Captab past and upcoming board meetings.

#Ex-Date
PurposeNotes
121 Aug 2026
Audited Results-
211 Aug 2026
Quarterly Results-
307 May 2026
Audited Results-
423 Jan 2026
Quarterly Results, Dividend & OthersTo consider other business matters.
507 Nov 2025
Quarterly Results-

Innova Captab Research Reports

Innova Captab research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
118 Oct 2024BP Wealth865746Buy15.95%35.79%pdf
219 Dec 2023SBI Securities--IPO Subscribe--%pdf
319 Dec 2023Hem Securities--IPO Subscribe--%pdf
419 Dec 2023Ventura--IPO Subscribe--%pdf

Innova Captab Corporate Filings

Innova Captab BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
07 Oct 2026
Innova Captab Ltd - 544067 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the certificate dated 07th October, 2026 received from KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2026.
PDF
05 Oct 2026
Innova Captab Ltd - 544067 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gian Parkash Aggarwal & PACs
PDF
02 Oct 2026
Innova Captab Ltd - 544067 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We wish to inform you that 22nd Annual General Meeting ("AGM") of the Company was held on Wednesday, 30th September, 2026 at 11.00 A.M. through Video Conferencing ("VC") / Other Audio Visual means ("OAVM") in accordance with the circular(s) issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Pursuant to applicable provisions of the Lising Regulations, we enclosed herewith details of Voting Results pursuant to regulation 44 of Listing Regulations and Scrutinizer Report.
PDF
30 Sep 2026
Innova Captab Ltd - 544067 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to the provisions of regulation 30 read with part A of schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed a summary of the proceedings of the 22nd Annual General Meeting ("AGM") of Innova Captab Limited held today i.e. 30th September, 2026 at 11:00 A.M. (IST) through Video Conferencing/ Other Audio-Visual Means ("VC/OAVM"). The AGM concluded at 11:30 A.M. (IST).
PDF
29 Sep 2026
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to regulation 30 read with part A of schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that M/s. CARE Ratings Limited, a credit rating agency, has revised the credit ratings on banking facilities of the Company. A copy of the rating letter including all requisite details is enclosed.
PDF

Innova Captab DocumentsAsk MarketMind AI

Innova Captab Earnings Call

Innova Captab earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
14 Aug 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14 May 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
02 Feb 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
02 Feb 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
27 Jan 2026Innova Captab Results Earnings Call for Q3FY26

Innova Captab Annual Reports

Innova Captab financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024

Innova Captab Credit Ratings

Innova Captab credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
06 Oct 2026care ratingsInnova Captab Limited
16 Apr 2026care ratingsInnova Captab Limited
18 Sep 2025care ratingsInnova Captab Limited
03 Sep 2024care ratingsInnova Captab Limited

Innova Captab Investor Presentations

Innova Captab investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
07 May 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
23 Jan 2026Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
07 Nov 2025Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
07 Aug 2025Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
19 May 2025Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation

Innova Captab - Company Profile

Innova Captab Management Structure

Innova Captab management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Lokesh BhasinChief Financial Officer95.2Mar 26
Mr. Mukeshkumar Siyaram SinghDeputy Chief Financial Officer36.23Mar 26
NEEHARIKA SHUKLACompany Secretary,Compliance Officer15Mar 26
Mr. Sujit Kumar DanaEmployee-Mar 26
Mr. Satyendra KumarEmployee-Mar 26
Mr. Arvind Kumar SinghEmployee-Mar 26
Mr. Girdhari Lal YadavEmployee-Mar 26
Mr. Jatinder Singh MahantEmployee-Mar 26
Mr. Himanshu AgarwalEmployee-Mar 26
Mr. Rajesh Kumar SharmaEmployee-Mar 26
Mr. Tarang SharmaEmployee-Mar 26
Mr. Narayan Venkatrao PatilEmployee-Mar 26
Ms. Anshika LohariwalaEmployee-Mar 26

Innova Captab Board of Directors

Innova Captab Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Manoj Kumar LohariwalaChairman & Exec. Director148.27Mar 26
Vinay Kumar LohariwalaManaging Director148.27Mar 26
Jayant Vasudeo RaoE D & Wholetime Director19.72Mar 26
NEEHARIKA SHUKLACompany Sec. & Compli. Officer15Mar 26
SUDHIR KUMAR BASSIIndependent Non Exe. Director7.6Mar 26
Shirish Gundopant BelapureIndependent Non Exe. Director4.6Mar 26
Mahendar KorthiwadaIndependent Non Exe. Director4.45Mar 26
Priyanka Dixit SibalIndependent Non Exe. Director2.95Mar 26
Anchit AggarwalNon-Exec & Non-Independent Dir-Mar 26

About the company - Business Profile

Innova Captab Ltd. is a vertically integrated pharmaceutical company with a presence across the entire value chain, including research and development (R&D), manufacturing, and marketing. The company operates in three primary business segments: Contract Development and Manufacturing Organization (CDMO) services, domestic branded generics, and international branded generics. As of FY25, Innova Captab serves over 200 CDMO customers, including some of India's leading pharmaceutical companies, and maintains a vast distribution network across India.

Key Points

  • Key Facts: Founded in 2005 and headquartered in Mumbai, Maharashtra (Registered Office) and Panchkula, Haryana (Corporate Office), Innova Captab is listed on the BSE and NSE. The company is led by promoters Manoj Kumar Lohariwala and Vinay Kumar Lohariwala.
  • Operations and Resources: The company operates manufacturing units in Baddi (Himachal Pradesh) and has recently commercialized a facility in Kathua, Jammu in January 2025. It also operates an API manufacturing unit in Taloja and is operationalizing a second R&D center in Panchkula, Haryana, by H2 FY2026.
  • Privatization and Ownership: The company is promoter-led, with the Lohariwala family holding significant control. Major milestones include the acquisition of Sharon Bio-Medicine Limited and a successful IPO in FY24.
  • Market Significance: Innova Captab plays a critical role in the Indian pharmaceutical ecosystem, providing manufacturing services for approximately 3,300 CDMO products and offering a portfolio of over 750 domestic branded generics. Its reach extends to 220,000+ pharmacy touchpoints.
  • Revenue Breakdown (FY25 Consolidated):
    • CDMO: ₹6,599 million (53% of revenue)
    • Domestic Branded Generics: ₹2,239 million (18% of revenue)
    • Sharon (Subsidiary): ₹1,989 million (16% of revenue)
    • International Branded Generics: ₹1,617 million (13% of revenue)
    • Total Revenue: ₹12,437 million (FY25) compared to ₹10,813 million in FY24.
  • Financial Highlights:
    • EBITDA: ₹1,982 million in FY25 (Margin: 15.9%).
    • PAT: ₹1,283 million in FY25 (Margin: 10.3%).
    • ROE: 13.4% in FY25.
  • Key Products and Technology: The company focuses on diverse therapeutic areas and complex generics. It recently received GMP compliance certifications from UK-MHRA for its Cephalosporin unit in Baddi and from PIC/s (SMDC, Ukraine) for its Jammu facility.
  • Subsidiaries: Key units include Univentis Medicare Limited and Sharon Bio-Medicine Limited.
  • Strategic Initiatives: The company is expanding its international footprint, particularly in regulated markets like the UK and Canada. Strategic focus remains on increasing wallet share with existing CDMO clients and scaling up production at the new Jammu facility to meet growing demand.

References

  1. Annual Report May 2025
  2. Investor Presentation Jan 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024
  5. Investor Presentation May 2026

Innova Captab FAQ

Innova Captab today is trading in the red, down by 1.2% at ₹1,013.
Innova Captab is currently trading down 1.2% on an intraday basis. In the past week the stock rose 2.6%. Stock has been up 3.98% in the past quarter and rose 21.89% in the past year. You can view this in the share price history/seasonality section.
Innova Captab is listed on NSE with the ticker INNOVACAP and on BSE as 544067. It's currently trading on NSE at a share price of ₹1,013 and on BSE with a share price of ₹1,015.
The market cap of Innova Captab is ₹5,796.88 Cr. as of Nov 02, 2026.
Innova Captab announced a INTERIM dividend of 20% which equals ₹2 in Jan 30, 2026.To view the full dividend history of Innova Captab click here.
Innova Captab has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Innova Captab reported ₹472.86 Cr. in revenue, ₹44.13 Cr. in net profit, and ₹75.12 Cr. in EBITD as of Aug 11, 2026 for Q1 FY26-27.
According to the predictions of 2 analysts, the share price prediction for Innova Captab is ₹1,116 with an upside of 10%.
The PE ratio of Innova Captab is 37.64 as of Nov 02, 2026.
The PB ratio of Innova Captab is 5.11 as of Nov 02, 2026.
There are no analyst reports for Innova Captab.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.